RxDoctor Payments Data

Kelli McCoy, NP

Family · Hagerstown, INNPI 1154681096

Payments from drug & device makers

$436in general payments, 2019–2025

Across 24 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$88
  • Takeda Pharmaceuticals U.S.A., Inc.$61
  • Novo Nordisk$60
  • AstraZeneca$58
  • GSK$52
  • Otsuka America Pharmaceutical, Inc.$41
  • plus $76 from 3 others

What the payments were for

  • Food & beverage$42597%
  • Education$123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$436 in reported general payments places this provider in the 50th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$14,412
Medicare patients
99
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$22,746
VraylarCariprazine Hcl14$19,993
EliquisApixaban18$13,644
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$9,641
LevemirInsulin Detemir15$1,611
Nebivolol Hcl16$1,507
Atorvastatin Calcium138$1,093
Losartan Potassium106$807
Gabapentin58$806
Atomoxetine Hcl11$785
Ondansetron Hcl26$755
Levothyroxine Sodium73$676
Albuterol Sulfate HfaAlbuterol Sulfate32$636
Ventolin HfaAlbuterol Sulfate11$618
Ipratropium Bromide14$525

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Levemir$60$24,35639 claims
AbbVieVraylar$88$19,99314 claims
GSKTrelegy Ellipta$52$9,64112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,392 family providers in Indiana.

Other family in Hagerstown

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →